Sign Up to like & get
recommendations!
1
Published in 2022 at "JAMA Cardiology"
DOI: 10.1001/jamacardio.2022.3750
Abstract: Key Points Question When are the clinical benefits of the sodium glucose cotransporter 2 inhibitor dapagliflozin first apparent among patients with heart failure with mildly reduced or preserved ejection fraction? Findings In this prespecified secondary…
read more here.
Keywords:
heart failure;
mildly reduced;
patients heart;
heart ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "European journal of heart failure"
DOI: 10.1002/ejhf.3682
Abstract: Anaemia is common in heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF) and associated with poor clinical outcomes. While renin–angiotensin system blockers reduce haemoglobin, little is known about the effect of mineralocorticoid receptor…
read more here.
Keywords:
anaemia;
mildly reduced;
heart failure;
failure mildly ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Diabetes"
DOI: 10.1111/dom.16512
Abstract: Obesity is a major risk factor for heart failure with mildly reduced or preserved ejection fraction (HFpEF). This meta‐analysis of randomised clinical trials (RCTs) evaluated the effects of incretin‐based therapies (IBTs), including glucagon‐like peptide‐1 receptor…
read more here.
Keywords:
reduced preserved;
failure mildly;
mildly reduced;
ejection fraction ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "European Journal of Clinical Investigation"
DOI: 10.1111/eci.14205
Abstract: The present study aims to clarify the prevalence and prognostic impact of anaemia and iron deficiency in patients with heart failure with mildly reduced ejection fraction (HFmrEF).
read more here.
Keywords:
reduced ejection;
anaemia iron;
heart failure;
mildly reduced ... See more keywords